ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
PACER – A multicentre, single-arm, two-stage, phase 2 study of panitumumab in patients with cetuximab-refractory metastatic colorectal cancer (mCRC)
Annals of Oncology
◽
10.1093/annonc/mdw335.22
◽
2016
◽
Vol 27
◽
pp. iv46
Author(s):
B. Daniele
◽
R.V. Iaffaioli
◽
C. Chiara
◽
E. Maiello
◽
G. Rosati
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase 2
◽
Two Stage
◽
Phase 2 Study
Download Full-text
Related Documents
Cited By
References
Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial
Clinical Colorectal Cancer
◽
10.1016/j.clcc.2020.05.009
◽
2020
◽
Vol 19
(4)
◽
pp. 270-276
Author(s):
Maria Carmela Piccirillo
◽
Antonio Avallone
◽
Chiara Carlomagno
◽
Evaristo Maiello
◽
Gerardo Rosati
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase 2
◽
Two Stage
◽
Phase 2 Study
Download Full-text
Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203)
Cancer
◽
10.1002/cncr.30967
◽
2017
◽
Vol 124
(4)
◽
pp. 688-697
Author(s):
Neal J. Meropol
◽
Yang Feng
◽
Jean L. Grem
◽
Mary F. Mulcahy
◽
Paul J. Catalano
◽
...
Keyword(s):
Colorectal Cancer
◽
Cancer Research
◽
Metastatic Colorectal Cancer
◽
Thymidylate Synthase
◽
Research Group
◽
Treatment Selection
◽
Phase 2
◽
Phase 2 Study
Download Full-text
Abstract 4461: Analysis of circulating tumor DNA (ctDNA) identifies on-treatment genomic alterations in a phase 2 study of veliparib plus FOLFIRI ± bevacizumab vs. placebo plus FOLFIRI ± bevacizumab in metastatic colorectal cancer (mCRC)
10.1158/1538-7445.sabcs18-4461
◽
2019
◽
Author(s):
Cyril Y. Ramathal
◽
Erin Murphy
◽
Elizabeth Asque
◽
Arne Jason Grundstad
◽
Peter Ansell
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Circulating Tumor Dna
◽
Phase 2
◽
Genomic Alterations
◽
Phase 2 Study
◽
Tumor Dna
Download Full-text
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients
British Journal of Cancer
◽
10.1038/s41416-019-0537-z
◽
2019
◽
Vol 121
(5)
◽
pp. 378-383
◽
Cited By ~ 1
Author(s):
Elena Elez
◽
Carles Pericay
◽
Manuel Valladares-Ayerbes
◽
Inmaculada Bando
◽
Maria Jose Safont
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Cancer Patients
◽
Salvage Therapy
◽
Phase 2
◽
Wild Type
◽
Exon 2
◽
Phase 2 Study
◽
Colorectal Cancer Patients
◽
Kras Exon
Download Full-text
A multicenter phase 2 study of irinotecan (CPT-11) and doxifluridine (5’-DFUR), an intermediate form of capecitabine, for metastatic colorectal cancer (MCRC)
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.3698
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 3698-3698
Author(s):
M. Ikenaga
◽
T. Kato
◽
H. Mishima
◽
M. Fukunaga
◽
K. Murata
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Intermediate Form
◽
Phase 2
◽
Multicenter Phase
◽
Phase 2 Study
Download Full-text
Extended RAS analysis and subsequent anti-EGFR and anti-VEGF treatment (tx) in PEAK: A first-line phase 2 study of FOLFOX6 + panitumumab (pmab) or bevacizumab (bev) in metastatic colorectal cancer (mCRC).
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.3629
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. 3629-3629
◽
Cited By ~ 4
Author(s):
Fernando Rivera
◽
Lee Steven Schwartzberg
◽
Meinolf Karthaus
◽
Gianpiero Fasola
◽
Jean-Luc Canon
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase 2
◽
First Line
◽
Anti Vegf
◽
Phase 2 Study
Download Full-text
ENCORE 601: A phase 2 study of entinostat in combination with pembrolizumab in patients with microsatellite stable metastatic colorectal cancer.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.3557
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. 3557-3557
◽
Cited By ~ 7
Author(s):
Nilofer Saba Azad
◽
Keisuke Shirai
◽
Autumn Jackson McRee
◽
Mateusz Opyrchal
◽
Douglas Buckner Johnson
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase 2
◽
Phase 2 Study
Download Full-text
Phase 2 Study of Modified Irinotecan and Bolus 5-Fluorouracil/l-Leucovorin in Japanese Metastatic Colorectal Cancer Patients
Advances in Therapy
◽
10.1007/s12325-012-0002-3
◽
2012
◽
Vol 29
(3)
◽
pp. 287-296
Author(s):
Eishi Baba
◽
Hiromitsu Fujishima
◽
Akitaka Makiyama
◽
Keita Uchino
◽
Risa Tanaka
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Cancer Patients
◽
Phase 2
◽
Phase 2 Study
◽
Colorectal Cancer Patients
Download Full-text
A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer
Cancer
◽
10.1002/cncr.31309
◽
2018
◽
Vol 124
(11)
◽
pp. 2337-2346
◽
Cited By ~ 16
Author(s):
Michael J. Pishvaian
◽
Rebecca S. Slack
◽
Wei Jiang
◽
A. Ruth He
◽
Jimmy J. Hwang
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Parp Inhibitor
◽
Phase 2
◽
Phase 2 Study
◽
Heavily Pretreated
Download Full-text
Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study
OncoImmunology
◽
10.1080/2162402x.2018.1474319
◽
2018
◽
Vol 7
(9)
◽
pp. e1474319
◽
Cited By ~ 19
Author(s):
Nicolas Isambert
◽
Alice Hervieu
◽
Cedric Rébé
◽
Audrey Hennequin
◽
Christophe Borg
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase 2
◽
Phase 2 Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close